2023
DOI: 10.1016/j.ejpb.2023.04.009
|View full text |Cite
|
Sign up to set email alerts
|

Improvement and characterization of oral absorption behavior of clofazimine by SNEDDS: Quantitative evaluation of extensive lymphatic transport

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2025
2025

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(2 citation statements)
references
References 52 publications
0
2
0
Order By: Relevance
“…Nevertheless, given the high content in Capryol 90:Imwitor 948, the studied NE might have the potential to provide a means to obtain a high concentration of lipophilic substances with a good solubility profile in this oil mixture. When compared to other oils, Capryol 90, in higher proportion in our formula, has shown to be the better solubilizer (among those tested) for very lipophilic drugs such as simvastatin (105 mg/mL [ 29 ]), clofazimine (18 mg/mL, [ 30 ]), luliconazole [~75 mg/mL [ 31 ]), terconazole (116 mg/mL [ 32 ]), tolvaptan (11 mg/g [ 33 ]), and even novel drug candidates such as JIN-001 (41 mg/mL [ 34 ]) and AC1497 (45 to 50 mg/mL [ 35 ]), to mention just a few examples. Precipitation upon dilution is not expected to occur since no water-miscible co-solvents account for the initial drug solubilization, and droplet size does not reduce upon dilution and is shown to provide a slow release of phenytoin used as the model drug.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Nevertheless, given the high content in Capryol 90:Imwitor 948, the studied NE might have the potential to provide a means to obtain a high concentration of lipophilic substances with a good solubility profile in this oil mixture. When compared to other oils, Capryol 90, in higher proportion in our formula, has shown to be the better solubilizer (among those tested) for very lipophilic drugs such as simvastatin (105 mg/mL [ 29 ]), clofazimine (18 mg/mL, [ 30 ]), luliconazole [~75 mg/mL [ 31 ]), terconazole (116 mg/mL [ 32 ]), tolvaptan (11 mg/g [ 33 ]), and even novel drug candidates such as JIN-001 (41 mg/mL [ 34 ]) and AC1497 (45 to 50 mg/mL [ 35 ]), to mention just a few examples. Precipitation upon dilution is not expected to occur since no water-miscible co-solvents account for the initial drug solubilization, and droplet size does not reduce upon dilution and is shown to provide a slow release of phenytoin used as the model drug.…”
Section: Discussionmentioning
confidence: 99%
“…Immediately before the experiment, the medium was replaced by 50 µL of complete fresh medium plus 50 µL of NE preconcentrates diluted in fresh medium at twice the concentration selected for treating the cells. Cells were then incubated for 30 The fluorescence intensity of plate wells was measured using an excitation wavelength of 570 nm and emission wavelength of 590 nm in a microplate fluorophotometer (Spectramax GeminiTM EM, Molecular Devices, LLC, San Jose, CA, USA). After subtracting background fluorescence (wells with blank resazurin solution), cell viability data were expressed as a percentage of the negative control of non-treated cells.…”
Section: Cell Culture and Cytotoxicity Evaluationmentioning
confidence: 99%